Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 44.71B | 60.76B | 59.60B | 60.07B | 52.44B | 50.72B |
Gross Profit | 11.32B | 27.37B | 25.18B | 24.17B | 22.18B | 22.04B |
EBITDA | 8.60B | 11.74B | 11.99B | 13.07B | 10.82B | 10.72B |
Net Income | 3.80B | 5.74B | 6.49B | 7.64B | 6.05B | 5.58B |
Balance Sheet | ||||||
Total Assets | 76.00B | 79.75B | 75.27B | 77.82B | 75.09B | 67.66B |
Cash, Cash Equivalents and Short-Term Investments | 5.37B | 7.63B | 6.11B | 5.52B | 4.50B | 6.30B |
Total Debt | 32.02B | 30.66B | 28.59B | 28.44B | 29.67B | 26.77B |
Total Liabilities | 56.07B | 57.20B | 54.50B | 56.12B | 55.35B | 50.00B |
Stockholders Equity | 17.80B | 19.99B | 18.10B | 19.02B | 17.11B | 15.27B |
Cash Flow | ||||||
Free Cash Flow | 5.83B | 7.55B | 7.68B | 5.66B | 6.73B | 8.13B |
Operating Cash Flow | 7.30B | 9.52B | 9.43B | 7.28B | 7.97B | 9.06B |
Investing Cash Flow | -557.00M | -625.00M | -2.29B | 2.45B | -3.25B | -1.48B |
Financing Cash Flow | -6.26B | -6.94B | -7.19B | -8.89B | -7.10B | -5.80B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | £109.87B | 24.06 | 28.78% | 3.28% | -2.98% | -16.91% | |
75 Outperform | 38.27B | 31.15 | 21.29% | 3.69% | -2.41% | -16.41% | |
66 Neutral | 86.63B | 28.56 | 6.18% | 6.10% | -2.24% | 0.00% | |
65 Neutral | 14.06B | 11.14 | 13.01% | 3.16% | -0.38% | 14.68% | |
60 Neutral | 39.56B | 21.74 | 21.23% | 4.42% | -2.83% | -40.42% | |
50 Neutral | 327.20M | -57.39 | 0.00% | 1.89% | -2.67% | 89.86% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |